Canada markets closed

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.08000.0000 (0.00%)
At close: 10:50AM EST
Currency in CAD

Valuation Measures4

Market Cap (intraday) 11.23M
Enterprise Value 15.43M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.40
Price/Book (mrq)107.98
Enterprise Value/Revenue 6.54
Enterprise Value/EBITDA -3.88

Trading Information

Stock Price History

Beta (5Y Monthly) 0.24
52-Week Change 3-50.00%
S&P500 52-Week Change 3-13.20%
52 Week High 30.1700
52 Week Low 30.0800
50-Day Moving Average 30.0944
200-Day Moving Average 30.1007

Share Statistics

Avg Vol (3 month) 344.07k
Avg Vol (10 day) 340.18k
Shares Outstanding 5124.83M
Implied Shares Outstanding 6N/A
Float 888.24M
% Held by Insiders 126.83%
% Held by Institutions 10.00%
Shares Short (Oct 30, 2022) 44.33k
Short Ratio (Oct 30, 2022) 40.05
Short % of Float (Oct 30, 2022) 4N/A
Short % of Shares Outstanding (Oct 30, 2022) 40.00%
Shares Short (prior month Sept 29, 2022) 47k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 12, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Mar 12, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022

Profitability

Profit Margin -179.57%
Operating Margin (ttm)-169.46%

Management Effectiveness

Return on Assets (ttm)-38.52%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.39M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)5.60%
Gross Profit (ttm)568.44k
EBITDA -3.87M
Net Income Avi to Common (ttm)-4.29M
Diluted EPS (ttm)-0.0420
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.26M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)3.29M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.51
Book Value Per Share (mrq)-0.03

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A